The LundADose method for planar image activity quantification and absorbed-dose assessment in radionuclide therapy.

A new method for absorbed-dose assessment in radionuclide therapy is presented in this paper. The method is based on activity quantification by the conjugate-view methodology, applied to serial whole-body, anterior-posterior, scintillation-camera scans. The quantification method is an extension of previous studies, and includes separate corrections for attenuation, scatter, and overlapping organs. Further development has now been undertaken to take into account the capabilities of new dual-head camera systems with a built-in X-ray tube for anatomical imaging. Furthermore, the modeling of time-activity data is included, and dosimetric calculations based on the formalism by the Medical Internal Radiation Dose (MIRD) committee. To streamline absorbed-dose assessments for a large number of patient studies, the programs for quantification, image registration, and absorbed-dose calculations have been embedded in an envelop program termed LundADose, where calculations, to a great extent, are performed automatically. Evaluation of the whole-body activity quantification is performed for patients undergoing radioimmunotherapy by monoclonal antibodies labeled with (111)In or (90)Y.

[1]  Michael Ljungberg,et al.  A new method to obtain transmission images for planar whole-body activity quantification. , 2005, Cancer biotherapy & radiopharmaceuticals.

[2]  M. Ljungberg,et al.  A Monte Carlo program for the simulation of scintillation camera characteristics. , 1989, Computer methods and programs in biomedicine.

[3]  C. Divgi,et al.  Hematologic toxicity in radioimmunotherapy: dose-response relationships for I-131 labeled antibody therapy. , 2002, Cancer biotherapy & radiopharmaceuticals.

[4]  K Erlandsson,et al.  Registration of emission and transmission whole-body scintillation-camera images. , 2001, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[5]  Yuni Dewaraja,et al.  Update on hybrid conjugate-view SPECT tumor dosimetry and response in 131I-tositumomab therapy of previously untreated lymphoma patients. , 2003, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[6]  Katherine S Panageas,et al.  Patient-specific, 3-dimensional dosimetry in non-Hodgkin's lymphoma patients treated with 131I-anti-B1 antibody: assessment of tumor dose-response. , 2003, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[7]  Michael Ljungberg,et al.  An activity quantification method based on registration of CT and whole-body scintillation camera images, with application to 131I. , 2002, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[8]  Xiaowei Liu,et al.  3D absorbed dose calculations based on SPECT: evaluation for 111-In/90-Y therapy using Monte Carlo simulations. , 2003, Cancer biotherapy & radiopharmaceuticals.

[9]  Michael G Stabin,et al.  PHYSICAL MODELS AND DOSE FACTORS FOR USE IN INTERNAL DOSE ASSESSMENT , 2003, Health physics.